Reversal of age-dependent nuclear morphology by inhibition of prenylation does not affect lifespan in Caenorhabditis elegans

Nucleus

Volumn 1, Issue 6, 2010, Pages 499-505

  Bar, Daniel Z ^a   Gruenbaum, Yosef ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Farnesyl transferase inhibitor; Lamin; Motility; Nuclear structure; Nucleau envelope

Indexed keywords

GLIOTOXIN; LAMIN A; MANUMYCIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAENORHABDITIS ELEGANS; CELL MOTILITY; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; LIFESPAN; MOUSE; NONHUMAN; PROGERIA; PROTEIN PRENYLATION; SKIN CELL;

CAENORHABDITIS ELEGANS; MUS;

EID: 78549283099     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.1.6.13223     Document Type: Article

References (39)

1. Stuurman N, Heins S, Aebi U. Nuclear lamins: their structure, assembly and interactions. J Struct Biol 1998; 122:42-66.
2. Herrmann H, Bär H, Kreplak L, Strelkov SV, Aebi U. Intermediate filaments: from cell architecture to nanomechanics. Nat Rev Cell Mol Biol 2007; 8:562-73.
3. Goldman RD, Gruenbaum Y, Moir RD, Shumaker DK, Spann TP. Nuclear lamins: building blocks of nuclear architecture. Genes Dev 2002; 16:533-47.
4. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 2005; 6:21-31.
5. Boban M, Braun J, Foisner R. Lamins: 'structure goes cycling'. Biochem Soc Trans 2010; 38:301-6.
6. Worman HJ, Ostlund C, Wang Y. Diseases of the nuclear envelope. Cold Spring Harb Perspect Biol 2010; 2:000760.
7. Ramírez CL, Cadiñanos J, Varela I, Freije JM, López- Otín C. Human progeroid syndromes, aging and cancer: new genetic and epigenetic insights into old questions. Cell Mol Life Sci 2007; 64:155-70.
8. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008; 22:832-53.
9. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford Progeria Syndrome 2004; 101:8963-8.
10. Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 2005; 11:440-5.
11. Fong LG, Frost D, M M, Qiao X, Yang SH, Coffinier C, Young SG. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science 2006; 311:1621-3.
12. Meta M, Yang SH, Bergo MO, Fong LG, Young SG. Protein farnesyltransferase inhibitors and progeria. Trends Mol Med 2006; 12:480-7.
13. Yang SH, Meta M, Qiao X, Frost D, Bauch J, Coffinier C, et al. A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest 2006; 116:2115-21.
14. Varela I, Pereira S, Ugalde AP, Navarro CL, Suárez MF, Cau P, et al. Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging. Nat Med 2008; 14:767-72.
15. Cao K, Capell BC, Erdos MR, Djabali K, Collins FS. A lamin A protein isoform overexpressed in Hutchinson-Gilford progeria syndrome interferes with mitosis in progeria and normal cells. Proc Natl Acad Sci USA 2007; 104:3939-54.
16. McClintock D, Ratner D, Lokuge M, Owens DM, Gordon LB, Collins FS, Djabali K. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One 2007; 2:1269.
17. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974; 77:71-94.
18. Haithcock E, Dayani Y, Neufeld E, Zahand AJ, Feinstein N, Mattout A, et al. Age-related changes of nuclear architecture in Caenorhabditis elegans. Proc Natl Acad Sci USA 2005; 102:16690-5.
19. Haithcock E, Dayani Y, Neufeld E, Zahand AJ, Feinstein N, Mattout N, et al. Age-related changes of nuclear architecture in Caenorhabditis elegans. Proc Natl Acad Sci USA 2005; 102:16690-5.
20. Bar DZ, Neufeld E, Feinstein N, Gruenbaum Y. Gliotoxin reverses age-dependent nuclear morphology phenotypes, ameliorates motility, but fails to affect lifespan of adult Caenorhabditis elegans. Cell Motil Cytoskeleton 2009; 66:791-7.
21. Margalit A, Neufeld E, Feinstein N, Wilson KL, Podbilewicz B, Gruenbaum Y. Barrier to autointegration factor blocks premature cell fusion and maintains adult muscle integrity in C. elegans. J Cell Biol 2007; 178:661-73.
22. Wiesel N, Mattout A, Melcer S, Melamed-Book N, Herrmann H, Medalia O, et al. Laminopathic mutations interfere with the assembly, localization and dynamics of nuclear lamins. Proc Natl Acad Sci USA 2008; 105:180-5.
23. Ramot D, Johnson BE, Berry TLJ, Carnell L, Goodman MB. The Parallel Worm Tracker: a platform for measuring average speed and drug-induced paralysis in nematodes. PLoS One 2008; 3:2208.
24. Lee SS, Lee RY, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet 2003; 33:40-8.
25. Hara M, Han M. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. Proc Natl Acad Sci USA 1995; 92:3333-7.
26. Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 2008; 358:592-604.
27. Herndon LA, Schmeissner PJ, Dudaronek JM, Brown PA, Listner KM, Sakano Y, et al. Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature 2002; 419:808-14.
28. Young SG, Fong LG, Michaelis S, Prelamin A, Zmpste24, misshapen cell nuclei and progeria-New evidence suggesting that protein farnesylation could be important for disease pathogenesis. J Lipid Res 2005; 46:2531-58.
29. Navarro CL, Cau P, Lévy N. Molecular bases of progeroid syndromes. Hum Mol Genet 2006; 2:151-61.
30. Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ. Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 2006; 86:967-1008.
31. Mallampalli MP, Huyer G, Bendale P, Gelb MH, Michaelis S. Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 2005; 102:14416-21.
32. Yang SH, Bergo MO, Toth JI, Qiao X, Hu Y, Sandoval S, et al. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci USA 2005; 102:10291-6.
33. Ralle T, Grund C, Franke WW, Stick R. Intranuclear membrane structure formations by CaaX-containing nuclear proteins. J Cell Sci 2004; 117:6095-104.
34. Goldberg MW, Huttenlauch I, Hutchison CJ, Stick R. Filaments made from A- and B-type lamins differ in structure and organization. J Cell Sci 2008; 121:215-225.
35. Prufert K, Vogel A, Krohne G. The lamin CxxM motif promotes nuclear membrane growth. J Cell Sci 2004; 117:6105-16.
36. Brandt A, Papagiannouli F, Wagner N, Wilschbrauninger M, Braun M, Furlong EE, et al. Developmental control of nuclear size and shape by Kugelkern and Kurzkern. Curr Biol 2006; 16:543-52.
37. Collins JJ, Huang C, Hughe S, Kornfeld K. The measurement and analysis of age-related changes in Caenorhabditis elegans. WormBook, Ed. The C. elegans Research Community, WormBook; DOI/101895/ wormbook11371, http://wwwwormbookorg2008.
38. Kroll M, Arenzana-Seisdedos F, Bachelerie F, Thomas D, Friguet B, Conconi M. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem Biol 1999; 6:689-98.
39. Young SG, Meta M, Yang SH, Fong LG. Prelamin a farnesylation and progeroid syndromes. J Biol Chem 2006; 281:39741-5.